Thursday, August 23, 2012

Ethical Dilemmas Contribute to Weakness in FDA Postmarket Oversight

Ethical challenges are central to persistent "critical weaknesses" in the national system for ensuring drug safety, according to a commentary by former Institute of Medicine (IOM) committee members published today in the New England Journal of Medicine.

URL: http://www.disabled-world.com/medical/pharmaceutical/fda/postmarket.php

No comments:

Post a Comment